Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!

Product Image
Product Description

Increase your productivity to 5 kg+ per day with the FlowSyn™ Maxi from Uniqsis!

The FlowSyn Maxi is a versatile and highly productive continuous flow reactor for high throughput single reactions with two reagents. With a flow rate of up to 80 ml/ min and the option to use Uniqsis’ high capacity (60 ml) coil reactor, the FlowSyn Maxi is the ideal scale-up tool for increasing your output to multi kg per day.

The high resolution FlowSyn user interface quickly guides you through the process of setting up your desired flow chemistry reactions. Once set up, the system automatically runs the experiment and cleans itself at the end of the program cycle. Comprehensive safety features, including automatic pressure regulation and over-pressure shut-down, ensure safe operation at all times.

With its key flowpath components made of stainless steel, the FlowSyn Maxi is a highly robust system capable of operating at 260°C, 1400 psi, and withstanding contact with corrosive fluids such as sulphuric and nitric acid. Other flowpath options (such as Hastelloy® and PTFE) are available for maximum chemical compatibility.

Uniqsis offers extensive “plug and play” options for temperature controlled static mixers and coil reactors, including the FlowSyn 60 ml coil reactor kit specifically designed for scale up.

The high-throughput FlowSyn Maxi can be expanded with the Uniqsis Binary Pump Module (BPM) to provide 4 reagent inputs and with other FlowSyn modules for automated multi-experiment and multi-step combinatorial capability. Optional cooling modules, with cooling capacities down to -88°C, are available for controlling highly exothermic reactions.

If you are looking at improving the output of your flow chemistry experiments, consider the FlowSyn Maxi from Uniqsis. Scale-up has never been easier!

Uniqsis-FlowSyn-Maxi.gif

UniqsisFlowSynMaxiSecImage.gif

Product FlowSyn™ Maxi from Uniqsis – Scaling up your flow chemistry experiments has never been easier!
Company Uniqsis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Uniqsis
29 Station Road Shepreth Cambridgeshire SG8 6GB UK

Tel: +44 (0)845 864 7747

Email: info@uniqsis.com



Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!